Skip to main content
. 2021 Nov 11;12:759172. doi: 10.3389/fphar.2021.759172

FIGURE 6.

FIGURE 6

HT enhances the anti-tumor effect of anti-CD47 antibody. Tumor-bearing mice received the treatment schedule shown in (A). The tumors after treatment in each group (n = 5) were separated and compared (B,C) (*p < 0.05, **p < 0.01).